Tag: pharma
-
What to Expect in Markets This Week: AMD, Palantir, Pharmaceutical and Tech Earnings; Private-Sector Employment Report
H2: A busy earnings slate sets the tone for markets this week Stock traders will be closely watching a flurry of earnings reports and economic data that could shape market sentiment over the next few days. Artificial intelligence demand remains a central theme for investors, with chipmakers and tech software groups expected to outline how…
-
Coldrif Cough Syrup Scandal: MP Arrests Pharma Owner G Ranganathan as 21 Deaths Linked
Overview: A Crisis Ties a Chennai Firm to Tragic Deaths The ongoing medical tragedy surrounding the Coldrif cough syrup has intensified with the arrest of G Ranganathan, the Chennai-based owner of Sresan Pharmaceuticals. A seven-member team from Madhya Pradesh police arrested Ranganathan as part of the investigation into the toxic cough syrup that has been…
-
Hong Kong Stocks Close Higher as Tech Sector Surges on AI Push
Market Overview Hong Kong’s equity market closed higher on October 2, with all main indices advancing. The tech sector led the charge, jumping more than 3% and hitting the strongest levels since November 2021. At the close, the Hang Seng Index rose 1.61% to 27,287.12, the Hang Seng Tech Index climbed 3.36% to 6,682.86, and…
-
Oncology, Immunology, and Diabetes: China’s Spectacular Leap in Therapeutic Innovation
China’s Rise as a Global Leader in Therapeutic Innovation In recent years, China has transformed from a manufacturing hub into a powerhouse of therapeutic innovation. Across oncology, immunology, and metabolic diseases like diabetes, researchers and companies are pushing the boundaries of how we diagnose, treat, and manage chronic conditions. This shift is not the result…
-
Trump Pharma Tariffs: Who Stands to Lose?
What the tariffs actually do In a post on Truth Social, former President Donald Trump announced a 100% tariff on branded or patented pharmaceutical products imported into the United States, unless a company has an active project to build manufacturing capacity within the U.S. The policy is slated to take effect on October 1, 2025.…
-
Trump Pharma Tariffs: Who Loses Under New US Duties
Overview: A surprise tariff move with far-reaching implications In a move that mirrors previous tariff shocks, President Donald Trump announced steep new duties on US pharmaceutical imports via social media. He said that starting October 1, 2025, a 100% tariff would apply to branded or patented pharmaceutical products unless a company is building a manufacturing…
-
Stocks to Watch: Top Picks for September 22
Introduction As the stock market gears up for Monday, September 22, investors should keep a keen eye on specific stocks that could present promising opportunities for profit. This article highlights critical updates across various sectors including IT, infrastructure, oil, pharma, and real estate, providing insights into which companies may be worth watching. IT Sector Under…
-
Top Stocks to Watch on September 22 for Investment Opportunities
Introduction As the markets gear up for Monday, September 22, investors are advised to keep a keen eye on specific stocks that could present lucrative investment opportunities. With significant updates from various sectors including IT, infrastructure, oil, pharma, and real estate, this is a critical time for traders. Let’s dive into the stocks that are…